Eric Trac is a visionary healthcare investor and biopharmaceutical strategist with a unique blend of medical expertise and financial acumen, driving transformative growth in the healthcare sector. As a Senior Analyst & Director at Sarissa Capital Management, he leads activist investment strategies, evaluates public and private market opportunities, and serves as a board director at Lyndra Therapeutics. With a background in venture capital at Vida Ventures and Vivo Capital, he has played a pivotal role in high-impact transactions, including Bayer’s $4 billion acquisition of AskBio and Centessa Pharmaceuticals’ $250 million Series A. Trac’s deep scientific foundation stems from his MD and MBA from Stanford University and his research in biotechnology at MIT, where he graduated in the top 8% of his class. Recognized as one of *Business Insider’s* “14 Most Impressive Students at MIT,” he continues to leverage his expertise in medicine and finance to drive innovation, maximize shareholder value, and advance the future of biopharmaceuticals.